(Q70469315)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8394295%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

title

Phase II study of trimetrexate in previously untreated patients with hepatocellular carcinoma. Southwest Oncology Group study 8712 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8394295%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

author name string

W H Harvey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8394295%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

T R Fleming

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8394295%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

P J Goodman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8394295%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

J H Harvey

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8394295%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

S E Rivkin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8394295%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

J S MacDonald

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8394295%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

publication date

1 February 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8394295%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

11 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8394295%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8394295%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8394295%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

page(s)

45-46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8394295%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00873909

11 October 2019

exact match

0 references

cites work

Pharmacokinetics of trimetrexate (NSC 352122) in monkeys.

1 reference

12 December 2020

2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline (tmq), a potent non-classical folate antagonist inhibitor--I effect on dihydrofolate reductase and growth of rodent tumors in vitro and in vivo

1 reference

12 December 2020

Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate

1 reference

12 December 2020

Uptake and efficacy of trimetrexate (TMQ, 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl] quinazoline), a non-classical antifolate in methotrexate-resistant leukemia cells in vitro

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00873909

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8394295%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

1 reference